<DOC>
	<DOC>NCT00508495</DOC>
	<brief_summary>The aim of the study is to evaluate the therapeutic efficacy, safety and local tolerability of two different paracetamol-containing solutions in postoperative total hip replacement. They will be compared to placebo (a dummy treatment which contains no active ingredient).</brief_summary>
	<brief_title>Analgesic Efficacy, Safety and Tolerability of Two Paracetamol-Containing Solutions in Post-Surgical Hip Replacement Pain</brief_title>
	<detailed_description />
	<mesh_term>Pain, Postoperative</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Analgesics</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>ASA I, II or III and scheduled for elective total hip replacement, using a standard approach and a cemented implant. Moderate or severe pain within 4 hours after stopping the PCA in the morning of the first postoperative day. Another acute or chronic painful physical condition Use of any other analgesics (within 24 hours), sedatives, or narcotic drugs as well as microsomal enzyme inducers Inability to use and understand Visual Analog Scale and Verbal Rating Score</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>pain, postoperative</keyword>
	<keyword>replacement, total hip</keyword>
	<keyword>total hip replacement</keyword>
	<keyword>arthroplasty, replacement, hip</keyword>
</DOC>